REXADEV - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
87146623
Word Mark
REXADEV
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-09-07
Filing Date
2016-08-22
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2017-06-06
Attorney Name
Law Office Assigned Location Code
L20
Employee Name
AGOSTO, GISELLE MARIE
Statements
Goods and Services
pharmaceutical preparations, biosimilars and pharmaceutical substances used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, blood cells, blood vessel, and blood diseases and disorders; pharmaceutical preparations, biosimilars and pharmaceutical substances for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, dermatological, pulmonary, respiratory, oncological, hepatological, lymphomas, leukemias, ophthalmic, transplant rejection, cardiovascular, endocrine, neurological, sleep, muscular, and psychiatric diseases and disorders; pharmaceutical preparations and biosimilars, namely, pharmaceutical preparations and pharmaceutical substances used for the treatment of arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis related arthritis, osteoarthritis, peripheral spondyloarthritis, polymyalgia rheumatic, spondyloarthropathies, acute disc prolapse, inflammatory bowel disease, Crohn's disease, ulcerative colitis, Intestinal Behçet's Disease, chronic pouchitis, small bowel lesions, Hermansky-Pudlak syndrome, autoimmune pancreatitis, multiple myeloma, multiple sclerosis, systemic lupus erythematosus, lupus nephritis, chronic inflammatory demyelinating polyneuropathy, autoimmune anemia, autoimmune hemolytic anemia, pure red cell aplasia, idiopathic thrombocytopenic purpura, Evans syndrome, type 1 diabetes mellitus, Sjogren's syndrome, encephalitis, IgG4-related disease, Devic's disease, myositis, psoriasis, psoriasis vulgaris, psoriasis arthropica, plaque psoriasis, palmoplantar psoriasis, hidradenitis suppurativa, bullous skin disorder, pemphigus, pemphigoid, kawasaki disease, interstitial cystitis, sleep apnea, sarcoidosis, retinal vascular disorders, age-related macular degeneration, refractory diabetic macular edema, uveitis, childhood uveitis, uveitic macular edema, choroidal neovascularization, Graves' ophthalmopathy, pyoderma gangrenosum, giant cell arteritis, Netherton syndrome, anaplastic thyroid cancer, breast cancer, ovarian cancer, cervical cancer, gastric cancer, colorectal cancer, non-squamous non-small cell lung cancer, glioblastoma, renal cell carcinoma, head and neck cancer, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, lymphocyte predominant subtype of Hodgkin's Lymphoma, vasculitis, granulomatosis with polyangiitis, microscopic polyangiitis, graft-versus-host disease, graft-versus-host disease following allogenic hematopoietic stem cell transplantation, graft-versus-host disease following keratoprosthesis, kidney transplant, asthma, chronic fatigue syndrome, major depression, and bipolar depression
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2016-08-25
Primary Code
005
Correspondences
Name
Timothy J. Gaul
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2016-08-25 | NEW APPLICATION ENTERED IN TRAM |
2016-08-25 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2016-10-28 | ASSIGNED TO EXAMINER |
2016-10-31 | NON-FINAL ACTION WRITTEN |
2016-10-31 | NON-FINAL ACTION E-MAILED |
2016-10-31 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2017-04-24 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2017-04-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2017-04-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2017-04-25 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2017-04-26 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2017-05-17 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2017-06-06 | PUBLISHED FOR OPPOSITION |
2017-06-06 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2017-08-01 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2018-01-25 | TEAS EXTENSION RECEIVED |
2018-01-25 | EXTENSION 1 FILED |
2018-01-25 | EXTENSION 1 GRANTED |
2018-01-27 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2018-07-12 | TEAS EXTENSION RECEIVED |
2018-07-12 | EXTENSION 2 FILED |
2018-07-12 | EXTENSION 2 GRANTED |
2018-07-14 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-01-22 | TEAS EXTENSION RECEIVED |
2019-01-22 | EXTENSION 3 FILED |
2019-01-22 | EXTENSION 3 GRANTED |
2019-01-24 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-03-07 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2019-03-07 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2019-05-24 | TEAS EXTENSION RECEIVED |
2019-05-24 | EXTENSION 4 FILED |
2019-05-24 | EXTENSION 4 GRANTED |
2019-05-28 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2019-11-20 | TEAS EXTENSION RECEIVED |
2019-11-22 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2019-11-20 | EXTENSION 5 FILED |
2019-11-22 | EXTENSION 5 GRANTED |
2019-11-23 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-09-07 | ABANDONMENT - NO USE STATEMENT FILED |
2020-09-08 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |